X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-09-25 | NCT | Intercont (Cayman) Ltd | Zhu Muchun | CEO, COB | P - Purchase | $0.40 | +1,625,000 | 1,831,598 | +787% | +$650,000 | ||||||
| DM | 2026-09-11 | HRGN | Harvard Apparatus Regenerative Technology, Inc. | He Junli | CEO | P - Purchase | $1.07 | +368,630 | 1,332,930 | +38% | +$394,459 | |||||
2026-09-23 | MSC | Studio City International Holdings Ltd | Ho Lawrence Yau Lung | Dir | P - Purchase | $0.20 | +1,043,600 | 464,139,192 | 0% | +$206,320 | ||||||
2026-09-23 | ANIX | Anixa Biosciences Inc | Titterton Lewis H Jr | Dir | P - Purchase | $2.69 | +49,036 | 1,046,003 | +5% | +$131,907 | ||||||
2026-09-24 | EDRY | Eurodry Ltd. | Pittas Aristeidis P | Dir | P - Purchase | $51.33 | +900 | 76,113 | +1% | +$46,199 | ||||||
2026-09-24 | AEF | Abrdn Emerging Markets Ex-China Fund, Inc. | Clark Anthony S. | Dir | P - Purchase | $9.63 | +4,500 | 6,000 | +300% | +$43,335 | ||||||
2026-09-24 | CMPX | Compass Therapeutics, Inc. | Lerner Neil | CHIEF ACCOUNTING OFFICER | P - Purchase | $1.14 | +2,500 | 400,000 | +1% | +$2,850 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |